EC Number   |
|---|
   1.11.1.24 | 1.5 A resolution crystal structure of peroxiredoxin 5 in the reduced form |
| 1.11.1.24 | 2.3 A resolution, microbatch method at 18°C, using a crystallization robot, TERA |
| 1.11.1.24 | crystal form of human peroxiredoxin 5 is described at 2.0 A resolution |
| 1.11.1.24 | crystallized using the vapour-diffusion method. The crystal grows in a condition consisting of 1.8 mol/l tri-ammonium citrate, pH 7.0 using 1 g/l protein solution at 16°C. A complete data set is collected from a crystal to 2.75 A resolution. The crystal belonged to space group P2(1)2(1)2(1), with unit-cell parameters a = 35.80 A, b = 50.63 A, c = 88.52 A, alpha = beta = gamma = 90°. One molecule is found in the asymmetric unit |
| 1.11.1.24 | enzyme complexed with thioredoxin Trx2 mutant C34S, sitting drop vapor diffusion method, using 25% (w/v) polyethylene glycol 3,350, 0.2 M lithium sulfate, 0.1 M HEPES-NaOH, pH 7.5 |
| 1.11.1.24 | hanging drop vapor diffusion method |
| 1.11.1.24 | hanging drop vapor diffusion method, using 0.1 M sodium citrate and 16% (w/v) ammonium sulfate, at pH 6.4 |
| 1.11.1.24 | hanging drop vapor diffusion method, using 30% (w/v) PEG 400, 200 mM MgCl2, and 100 mM HEPES pH 7.5 |
| 1.11.1.24 | hanging drop vapour diffusion method with 100 mM citrate (pH 4.6) and 10% polyethylene glycol |
| 1.11.1.24 | hanging-drop vapor-diffusion method, C45S/C50S double mutant crystallizes in the space group P2(1) with four molecules per asymmetric unit |
